Associate Professor Ekaphop Sirachainan he served as an instructor and Oncology Unit, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University. He received his medical degree from the Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. He completed a residency and fellowship in medical oncology at Ramathibodi Hospital, Mahidol University, and a research fellowship at the Division of Hematology/Oncology, Department of Internal Medicine, Michigan University, Michigan, USA. He has been certified by the Thai Medical Council of Thailand, Thai Board of Internal Medicine and Thai Board of Medical Oncology.
Assistant Professor Sirachaninan has been the Principal Investigator of several international clinical trials. He has published 30 original articles/abstracts, 11 book sections and presented 15 papers/posters at major national and international congresses. He is also the head of oncology unit, Ramathibodi hospital, President of the Thai Society of Clinical Oncology (TSCO), member of the Royal College of Physician (Thailand), American Society of Clinical Oncology (ASCO) and The European Society for Medical Oncology (ESMO).
Dr. Sriuranpong is currently the Vice President of the Thai Society of Clinical Oncology, Director of the Chualongkorn Clinical Research Center, and Associate Professor in Internal Medicine and Medical Oncology at Chulalongkorn University School of Medicine.
Dr. Sriuranpong began his medical training at Chulalongkorn University, where he earned his MD in 1990, followed by a specialty in internal medicine and oncology. He earned his PhD in Cellular and Molecular Medicine at Johns Hopkins University School of Medicine, US, and completed a fellowship in Oral and Pharyngeal Cancer at the National Institutes of Health, US.
Dr. Sriuranpong has conducted research into the genetic basis and biochemical mechanisms underlying various types of cancer, particularly lung and head and neck cancer.
Dr.Ithimakin has served as an instructor and medical oncologist at the Faculty of Medicine Siriraj Hospital, Mahidol University. She graduated from Faculty of Medicine Siriraj Hospital with first-class honors and gold medal award in 2000. She completed a residency and fellowship from same institution. She was awarded Anandamahidol Scholarship and spent more than a year as a research fellow in breast cancer stem cell at the University of Michigan Comprehensive Cancer Center, USA. She was the International Development and Education Award recipient in the ASCO meeting 2010. Dr.Ithimakin has participated in several clinical studies of anticancer agents for solid tumors and also supportive care for cancer patients. Her major interests are breast cancer, GI cancer and supportive treatment.
Radiation oncologist of Division of Radiation Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital/ Adjunct instructor, Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University
Visiting Scientist, University of Texas MD Anderson Cancer Center, Houston, US
Observership Program, Massachusetts General Hospital, Boston, US
Certificate of Short course in Health Science Research, Faculty of Medicine, Chulalongkorn University
Thai Board of Radiation Oncology
Higher Graduate Diploma of Clinical Sciences Program in Radiation Oncology, Chulalongkorn University, Bangkok
Observership Program, National Cancer Centre Singapore, Singapore
Residency training program of Division of Therapeutic Radiation and Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital (KCMH)
Doctor of Medicine (MD), Chulalongkorn University, Bangkok, Thailand–2nd class Honors
A medical oncologist and Assistant Professor at Khon Kaen University, Thailand. Received an MD (Doctor of Medicine) followed by a residency in Internal Medicine from Khon Kaen University. Completed medical oncology fellowship training at Chulalongkorn University. Former ASCO IDEA and Anandamahidol Foundation grant recipient. Research interests include genitourinary and hepatobiliary cancer.
High school Satriwithaya School Bangkok, Thailand
Doctor of Medicine
Faculty of Medicine Siriraj Hospital Mahidol University Bangkok, Thailand
Department of Medicine Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Fellowship of Medical Oncology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
2015 - Present
Instructor Division of Medical Oncology Department of Medicine
Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Thailand
Dr.Korphaisarn received her medical degree and completed her residency in Internal Medicine and Fellowship in Medical Oncology from Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand. Between January 2015 and June 2017, she worked as a researcher at the University of Texas MD Anderson Cancer Center, Houston, Texas, USA. She has been a faculty staff in the Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriaj Hospital since 2012. She is involved in conducting many clinical studies as a principal investigator and published many original articles in peer review journals. Her research interests include GI cancer, lung cancer, and translation research.
KunlatidaManeenil, M.D., is a medical oncologist and instructor in Internal Medicine and Medical Oncology at Rajavithi Hospital, where she worked since 2011.
Dr. Maneenil received her medical degree with first-class honors and the residency training in Internal Medicine from Prince of Songkla University, Thailand. She completed a clinical medical oncology fellowship at Rajavithi Hospital in 2011. She completed a postdoctoral research fellowship in Medical Oncology (Thoracic malignancy)
and received a certification of Clinical and Translation Science from Collage of Medicine, Mayo Clinic, Rochester, MN, USA in 2017. Her research interests include all areas of care related to thoracic malignancies and colorectal cancer.
Dr. Napa is the instructor at the Medical Oncology Unit in Chulalongkorn University. She received her fellowship training at Chulalongkorn University and then she got postdoctoral training at Breast Medical Oncology, MD Anderson Cancer Center for 2 ½ years. During her training at MD Anderson, she did basic science about drug discovery and translation research about triple-negative breast cancer subtype. Her researches mostly focus on triple-negative breast cancer biology in Thai women anddifferences of molecular aberrations between different ethnicities. She has been involved in international multi-center research which collaborates between America, Japan and Korea.
Dr. Napa is currently the member of Thai Society of Medical Oncology, Breast cancer research team. She and her team have conducted multi-center research about breast cancer tumor registry and a clinic pathological prediction model for recurrence in patients with early-staged hormonal receptor positive, Her-2 negative breast cancer in Thai women.
Nattaya Poovorawan, M.D., M.Sc., is currently an instructor and medical oncologist at Faculty of Medicine, Chulalongkorn University and Chulalongkorn Hospital since 2014. She received medical degree and Thai board of Internal Medicine from Khon Kaen University, followed by medical oncology fellowship at Chulalongkorn Hospital in 2013. Her special interests are breast, GU malignancy and geriatric oncology.
07/2011 – 06/2013
Drug Development Fellowship, Roswell Park Cancer Institute, University at Buffalo, Buffalo, NY
07/2009 – 06/2011
Medical Oncology Fellowship, Roswell Park Cancer Institute, University at Buffalo, Buffalo, NY
07/2006 – 06/2009
Internal Medicine Residency, Saint Vincent Hospital, University of Massachusetts Affiliate, Worcester, MA
06/1997 - 03/2003
Medical School King Chulalongkorn Memorial Hospital Chulalongkorn University, Bangkok, Thailand
10/2013 – present
Medical Oncology Unit, Dept of Medicine Ramathibodi Hospital Mahidol University, Bangkok Thailand
07/2011 – 06/2013
Drug Development Fellow Dept of Medicine, Roswell Park Cancer Institute/University at Buffalo Buffalo, NY USA.
07/2009 – 06/2011
Medical Oncology Fellow Dept of Medicine, Roswell Park Cancer Institute/University at Buffalo Buffalo, NY USA.
07/2006 – 6/2009
Medical Resident/Intern Dept of Medicine, Saint Vincent Hospital/University of Massachusetts Affiliate Worcester,MA USA.
04/2003 - 04/2006
Medical Resident/Intern Dept of Medicine, Sawanpracharak Hospital /Mahidol University Affiliate NaKhon-Sawan, Thailand.
Petch Alisanant,M.D. is a graduate of Chulalongkorn University, Faculty of Medicine. His higher graduate diploma was in clinical science from Chulalongkorn University and completed his resident training program of Radiation and Oncology where he earned himself the reputation of excellent cancer patient care and was awarded " The Best Practice Resident" Furthermore, he continued his post graduate training as a visiting fellow for Carbon Ion treatment at Gunma University, Japan. Dr.Alisanant has been practicing in Radiation Oncology since 2010. His practice focuses on hepatobiliary, gynecology , colorectal and prostate cancer. He is also the author/co-author/contributor to the many publications. Currently, Dr.Alisanant is a consultant in Radiation Oncology and an Assistant Director of Supporting Service , King Chulalongkorn Memorial Hospital. He is also a member of Institutional Review Board (IRB) and a consultant in Medical Student Affair, Faculty of Medicine, Chulalongkorn University.
Dr. Sitthideatphaiboon is currently working as the instructor of Chulalongkorn Comprehensive Cancer Center and Medical Oncology at The Faculty of Medicine of the Chulalongkorn University and the King Chulalongkorn Memorial Hospital.
Dr. Sitthideatphaiboon completed the M.D. in 2004, followed by residency training in internal medicine, fellowship in medical oncology and Master of Science from Chulalongkorn University. She got the IASLC/APLCC Lung Cancer Fellowship and Awards in 2014 and worked as visiting scientist in Department of Thoracic/ Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
2000- Mar 2006
Faculty of Medicine Chulalongkorn University 1st class honors (Bangkok Thailand)
Department of Medical oncology Faculty of Internal medicine Ramathibodi hospital, Mahidol University 21th June, 2014 Certificate of clinical and translation science from college of medicine, Mayo Clinic (Rochester, Minnesota, United state of America)
2013- Jan 2015
Research fellow (medical oncology) Mayo Clinic (Rochester, Minnesota, United State of America)
2010-April 2013 and Jan 2015- now Medical oncologist, department of internal medicine, Rajavithi Hospital (Bangkok Thailand)
Hematology/Oncology Fellowship, Roswell Park Cancer Institute, State University of New York, Buffalo, New York. American Board of Medical Oncology.American Board of Hematology.
Internal Medicine Residency, Greater Baltimore Medical Center, Baltimore, Maryland. Certified in American Board of Internal Medicine
Department of internal medicine, Faculty of medicine Siriraj Hospital, Mahidol University. Residency in internal medicine.
Faculty of Graduate Studies, Mahidol University, Bangkok, Thailand. Graduate Diploma in clinical science.
Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand. M.D. (First Class Honors)
Siriwimon Saichaemchan, M.D., is a medical oncologist and instructor in Internal Medicine and Medical Oncology at Phramongkutklao Hospital and College of Medicine. She completed her residency training in internal medicine from the same institution and received the honor to perform the oral research presentation of the Royal College of Physicians of Thailand (RCPT) in 2006. After completing a medical oncology fellowship from Faculty of Medicine Siriraj Hospital, Medical University in 2010, she received an opportunity to be a clinical observer which attend about modern novel treatment in lung cancer at Albert Einstein University, Bronx, NY and to be a visiting research fellow in the Cancer Molecular Cytogenetics Laboratory of University of Colorado, School of Medicine, Division of Medical Oncology at Anschutz Medical Campus Colorado, USA in 2015. Her research included molecular techniques especially FISH (fluorescence in-situ hybridization) in many solid cancers such as melanoma, cholangiocarcinoma, colon cancer, breast cancer and lung cancer. She also interests in lung cancer, breast cancer and hepatobiliary tract cancers.
Teerapat Ungtrakul is currently Assistant Dean of Administration and Education, Faculty of Medicine and Publich Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy. He is also Director of Clinical Research Management Unit. After his certified board training from Chulalongkorn University in 2012, He founded the Excellent Center of Liver Cancer at Chulabhorn Hospital,aiming to provided multidisplinary and holistic approach to liver cancer patients, which is the “number one” killing cancer in Thailand. Additionally, he is the principle investigator in large cohort study in liver cancer screening program in patients with chronic viral hepatitis B in collaboration with the government pharmaceutical organization (GPO). Ongoing area of research interest includes liver cancer, viral hepatitis and cancer screening.
Recent honous included Young Investigator Bursary Award (EASL monothermic conference 2013 and International Digestive Disease Forum 2013), Best abstract of the Year Award (Royal College of Physician of Thailand 2014, 2015)
Yotsawaj Runglodvatana, M.D., is a medical oncologist and instructor in Internal Medicine and Medical Oncology at Faculty of Medicine Vajira Hospital, Navamindradhiraj University. He received his medical degree from the Faculty of Medicine Vajira Hospital and completed a clinical medical oncology-training program from Siriraj Hospital, Mahidol University in 2010 and then has been worked in his field at Faculty of Medicine Vajira Hospital since 2010. In 2011 he received a grant from clinical oncology society of Australia to study in research methodology and palliative management which he is interested in.
Dr. Yotsawaj Runglodvatana is now chief of palliative care center of the Faculty of Medicine Vajira Hospital and principal investigator of several international clinical trials.